Clinical trials
Suspended Observational Prostatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hackensack Meridian Health | 1 |
| National Cancer Institute (NCI) | 1 |
| Primo Biotechnology Co., Ltd | 1 |
| Shanghai Changzheng Hospital | 1 |
| University of Arizona | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 7 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Colonic Neoplasms | 1 |
| Multiple Myeloma | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.